SCHEMBL7122210

SCHEMBL7122210

O=C(Nc1ccc(Br)cc1)c1ccccc1NS(=O)(=O)c1cccs1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.62
KMT2A Q03164 10/20 0.62
ALDH1A1 P00352 4/20 0.62
GAA P10253 2/20 0.62
KDM4E B2RXH2 2/20 0.62
HPGD P15428 2/20 0.62
HSD17B10 Q99714 1/20 0.62
MAPT P10636 6/20 0.57
LMNA P02545 6/20 0.57
MAPK1 P28482 2/20 0.57
POLB P06746 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.55
HTT P42858 4/20 0.54
RECQL P46063 2/20 0.54
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
BRAF P15056 2/20 0.49
HKDC1 Q2TB90 1/20 0.49
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127128 0.89 SLC10A2 (0.60) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL7126602 0.81 MEN1 (0.70) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL27179844 0.81 GAA (0.60) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL30926831 0.81 GAA (0.60) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL12435747 0.80 ALDH1A1 (0.63) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL16088703 0.78 HTT (0.70) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL12334082 0.77 MEN1 (0.67) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL27181565 0.77 MEN1 (0.55) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL30926899 0.77 MEN1 (0.55) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL7117950 0.77 SMN1; SMN2 (0.55) MEN1KMT2AALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216449-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-20 US claimed
CN-1429108-A Phosphate transport inhibitors SMITHKLINE BEECHAM CORP (US) 2003-07-09 CN claimed
EP-1202729-A1 PHOSPHATE TRANSPORT INHIBITORS SmithKline Beecham Corporation (US) 2002-05-08 EP claimed
WO-2001087294-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-22 WO claimed
WO-2001005398-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-01-25 WO claimed
US-20030216449-A1 Phosphate transport inhibitors SMITHKLINE BEECHAM CORPORATION 2003-11-20 US disclosed
CN-1429108-A Phosphate transport inhibitors SMITHKLINE BEECHAM CORP (US) 2003-07-09 CN disclosed
EP-1202729-A1 PHOSPHATE TRANSPORT INHIBITORS SmithKline Beecham Corporation (US) 2002-05-08 EP disclosed
WO-2001087294-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-22 WO disclosed
WO-2001005398-A1 PHOSPHATE TRANSPORT INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216449-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC34A3 MEN1 3779/4885KMT2A 4033/4885ALDH1A1 3945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.